(1)
Wan , X.; Zeng, Y.; Xiong, M.; Chen, L.; Bai, Y. FCGBP Inhibits the Development of LSCC and Cisplatin Resistance through the PIGR JAK2 STAT3 Pathway. Radiol Oncol 2026, 60, 67-75.